On the 16th, at the NH Investment & Securities headquarters in Yeongdeungpo, Seoul, Yoon Byung-woon, Head of IB1 Division at NH Investment & Securities (left), and Lee Joo-won, CEO of One Drop (right), are taking a commemorative photo after signing the lead underwriting agreement for One Drop's KOSDAQ listing. (Photo by NH Investment & Securities)

On the 16th, at the NH Investment & Securities headquarters in Yeongdeungpo, Seoul, Yoon Byung-woon, Head of IB1 Division at NH Investment & Securities (left), and Lee Joo-won, CEO of One Drop (right), are taking a commemorative photo after signing the lead underwriting agreement for One Drop's KOSDAQ listing. (Photo by NH Investment & Securities)

View original image


[Asia Economy Reporter Kum Boryeong] NH Investment & Securities has been selected as the lead underwriter for the KOSDAQ listing of 'OneDrop.'


OneDrop announced on the 17th that it signed a lead underwriting contract with NH Investment & Securities on the 16th, selecting them as the lead underwriter.


Starting with the selection of the underwriter, OneDrop will begin full-scale preparations for its KOSDAQ listing. It aims to list in 2022 through the technology evaluation special case system.


Founded in 2017, OneDrop began as an in-house venture of Samsung Electronics. This year, it was named a Baby Unicorn by the Ministry of SMEs and Startups and won the grand prize at the Gyeonggi Startup Competition.


Mobile healthcare company OneDrop researches, develops, and manufactures molecular diagnostic products based on a commercial smartphone-based chronic disease management solution business and molecular diagnostic technology capable of quantifying down to single molecules. It developed a molecular diagnostic reagent for COVID-19 and was the first in Korea to register with Canadian health authorities in March. In May, it obtained Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), becoming the sixth domestic company to do so, secured approvals in more than 15 countries worldwide, and is exporting to over 30 countries.



Kim Junggon, Head of ECM at NH Investment & Securities, explained, "As the market is expected to expand in the telemedicine sector, which is based on prevention, diagnosis, and monitoring, smart healthcare companies such as Livongo and Alibaba Health are gaining attention, and OneDrop's technological capabilities and growth potential will be further highlighted."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing